The data presented here identify GFT1803 as a highly efficient PPAR agonist, which prevents the development of pathological and behavioral hallmarks of AD in the AP/PS1 mouse model when given from early time points on. The gene discussed is DHCR7-DT; the disease is Alzheimer disease.